We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+9.09%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$18.6B
AUM Growth
+$370M
(+2%)
Cap. Flow
-$1.05B
Cap. Flow
% of AUM
-5.64%
Top 10 Holdings %
Top 10 Hldgs %
19.87%
Holding
1,286
New
95
Increased
394
Reduced
580
Closed
90
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$42.1M |
| 2 |
Amazon
AMZN
|
+$37.3M |
| 3 |
Agilent Technologies
A
|
+$34.9M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$34.7M |
| 5 |
Netflix
NFLX
|
+$33.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Progressive
PGR
|
+$132M |
| 2 |
Cencora
COR
|
+$65.6M |
| 3 |
Biogen
BIIB
|
+$53.3M |
| 4 |
Applied Materials
AMAT
|
+$44.9M |
| 5 |
Dollar General
DG
|
+$44.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.39% |
| 2 | Healthcare | 13.06% |
| 3 | Financials | 11.34% |
| 4 | Consumer Discretionary | 9.35% |
| 5 | Industrials | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
iShares Select Dividend ETF
DVY
$24.1B
| $18.8M | 0.1% |
165,166
-3,836
| -2% | -$405K |
|
|
MNDT
227
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $18.6M | 0.1% |
948,977
-256,387
| -21% | -$5.36M |
|
228
Merit Medical Systems
MMSI
$4.67B
| $18.5M | 0.1% |
308,150
+16,421
| +6% | +$941K |
|
229
Arcosa
ACA
$7.13B
| $18.4M | 0.1% |
283,032
-74,427
| -21% | -$4.57M |
|
230
Mettler-Toledo International
MTD
$28.1B
| $18.3M | 0.1% |
15,874
+13,402
| +542% | +$15.5M |
|
231
Mesa Laboratories
MLAB
$559M
| $18.3M | 0.1% |
75,113
+48,409
| +181% | +$13.3M |
|
|
UNVR
232
DELISTED
Univar Solutions Inc.
UNVR
| $18.2M | 0.1% |
843,286
-243,155
| -22% | -$4.98M |
|
233
Ingevity
NGVT
$2.59B
| $18.1M | 0.1% |
+239,387
| New | +$17.4M |
|
234
Hershey
HSY
$37.2B
| $17.9M | 0.1% |
113,156
-2,238
| -2% | -$337K |
|
235
STAG Industrial
STAG
$7.79B
| $17.9M | 0.1% |
531,658
-145,898
| -22% | -$4.66M |
|
236
Fox Class A
FOXA
$24.2B
| $17.9M | 0.1% |
494,438
+316,130
| +177% | +$11.1M |
|
237
EnerSys
ENS
$6.69B
| $17.6M | 0.1% |
194,266
-49,202
| -20% | -$4.5M |
|
238
Silgan Holdings
SLGN
$5.07B
| $17.5M | 0.09% |
416,958
+78,595
| +23% | +$3.07M |
|
239
Kohl's
KSS
$2.16B
| $17.4M | 0.09% |
292,121
-27,810
| -9% | -$1.43M |
|
240
Prestige Consumer Healthcare
PBH
$2.45B
| $17.4M | 0.09% |
394,090
-104,756
| -21% | -$4.4M |
|
241
Gilead Sciences
GILD
$167B
| $17.3M | 0.09% |
268,002
-268,308
| -50% | -$17.3M |
|
|
AAWW
242
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
| $17.2M | 0.09% |
284,544
-76,626
| -21% | -$4.28M |
|
243
Vanguard Small-Cap Value ETF
VBR
$37.7B
| $17.2M | 0.09% |
103,663
+1,333
| +1% | +$210K |
|
|
SYNH
244
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $17.1M | 0.09% |
225,015
-59,189
| -21% | -$4.46M |
|
|
VCRA
245
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $17M | 0.09% |
443,299
-113,184
| -20% | -$4.88M |
|
246
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.95B
| $17M | 0.09% |
303,432
-234,345
| -44% | -$14.1M |
|
247
Qorvo
QRVO
$8.09B
| $16.9M | 0.09% |
92,680
-768
| -0.8% | -$135K |
|
|
VG
248
DELISTED
Vonage Holdings Corporation
VG
| $16.9M | 0.09% |
1,432,183
-375,024
| -21% | -$4.88M |
|
249
AMN Healthcare
AMN
$1.35B
| $16.9M | 0.09% |
229,424
+29,270
| +15% | +$2.18M |
|
250
ICU Medical
ICUI
$4.14B
| $16.8M | 0.09% |
81,887
+7,296
| +10% | +$1.54M |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q1 2021 Portfolio in Review
As of Q1 2021, Glenmede Trust held 1,286 positions worth $18.6B, up 2% from $18.2B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Glenmede Trust withdrew a net $1.05B in Q1 2021, closing 90 positions and reducing 580 holdings. Its most notable exit was Coherent, an estimated $32.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Glenmede Trust opened a new position in Rollins worth $29.6M.
- Glenmede Trust's largest Q1 2021 buy was Rollins: 860,755 shares worth $29.6M.
- Glenmede Trust added most to State Street SPDR S&P 500 ETF Trust in Q1 2021, an estimated $42.1M increase.
- Glenmede Trust's biggest Q1 2021 reduction was Progressive, cutting an estimated $132M.
- Glenmede Trust fully exited Coherent in Q1 2021, selling an estimated $32.9M.
- Glenmede Trust's ten largest holdings make up 20% of its $18.6B portfolio in Q1 2021.
- Glenmede Trust opened 95 new positions and closed 90 in Q1 2021.
- Glenmede Trust's portfolio value rose 2% quarter-over-quarter to $18.6B.
Based on Glenmede Trust's 13F filing for Q1 2021, filed 18 May 2021.